Carl Zeiss Meditec AG (ETR: AFX)
Germany flag Germany · Delayed Price · Currency is EUR
46.62
+0.24 (0.52%)
Dec 27, 2024, 5:35 PM CET

Carl Zeiss Meditec AG Company Description

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia.

It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics, as well as digital products for storage, evaluation, and sharing of clinical data.

In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery.

The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries.

It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany.

Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Carl Zeiss Meditec AG
Country Germany
Founded 1846
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 4,823
CEO Markus Weber

Contact Details

Address:
Göschwitzer Straße 51-52
Jena, 07745
Germany
Phone 49 3641 220 115
Website zeiss.com

Stock Details

Ticker Symbol AFX
Exchange Deutsche Börse Xetra
Fiscal Year October - September
Reporting Currency EUR
ISIN Number DE0005313704
SIC Code 3845

Key Executives

Name Position
Markus Weber Chief Executive Officer
Justus Wehmer Chief Financial Officer
Stefanie Spanagel Chief Operating Officer
Sebastian Frericks Head of Investor Relations